Lin Z, Li J, Zhang J, Feng W, et al. Metabolic reprogramming driven by IGF2BP3 promotes acquired resistance to EGFR inhibitors in non-small cell lung cancer. Cancer Res 2023 Apr 16:CAN-22-3059. doi: 10.1158/0008-5472.CAN-22-3059.
PMID: 37061993